Safety and Efficacy Study for Treatment of Anemia in ESRD Newly Initiated Dialysis Patients (Himalayas)
This study is currently recruiting participants.
Verified May 2017 by FibroGen
Astellas Pharma Europe B.V.
Information provided by (Responsible Party):
First received: January 6, 2014
Last updated: May 4, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||March 2018|
|Estimated Primary Completion Date:||March 2018 (Final data collection date for primary outcome measure)|